SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-052619
Filing Date
2024-06-14
Accepted
2024-06-14 07:19:00
Documents
16
Period of Report
2024-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207886-8k425_redwood.htm   iXBRL 8-K 68248
2 FORWARD PURCHASE AGREEMENT, DATED JUNE 13, 2024, BY AND AMONG REDWOODS ACQUISITI ea020788601ex10-1_redwood.htm EX-10.1 205852
3 SUBSCRIPTION AGREEMENT, DATED JUNE 13, 2024, BY AND AMONG REDWOODS ACQUISITION C ea020788601ex10-2_redwood.htm EX-10.2 194995
  Complete submission text file 0001213900-24-052619.txt   801356

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rwod-20240613.xsd EX-101.SCH 3685
5 XBRL DEFINITION FILE rwod-20240613_def.xml EX-101.DEF 27225
6 XBRL LABEL FILE rwod-20240613_lab.xml EX-101.LAB 37384
7 XBRL PRESENTATION FILE rwod-20240613_pre.xml EX-101.PRE 25841
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0207886-8k425_redwood_htm.xml XML 7323
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Redwoods Acquisition Corp. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241043144
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)